13F-HR filed by Endurant Capital Management LP
Endurant Capital Management LP filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 52 holding rows worth $277,286,000.
- Accession
- 0001633055-21-000002
- Filer
- CIK 1633055
- Filed
- 2021-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 52 entries on the cover page, a total value of $277,286,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $277,286,000 with VALUE read as thousands by filing date, 13F file number 028-16634. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 2,240,421 | $39,129,000 | thousands by filing date | |
| BECTON DICKINSON & CO | 075887109 | COM | 69,264 | $17,331,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 244,066 | $15,139,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 655,741 | $9,646,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 84,544 | $9,059,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 56,231 | $8,850,000 | thousands by filing date | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 193,008 | $7,962,000 | thousands by filing date | |
| CENCORA INC COM | 03073E105 | Stock | 78,339 | $7,658,000 | thousands by filing date | |
| SI BONE INC | 825704109 | COM | 254,907 | $7,622,000 | thousands by filing date | |
| SMITH & NEPHEW PLC SPDN ADR NEW | 83175M205 | ADR | 179,138 | $7,554,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,126,675 | $7,290,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 22,634 | $7,268,000 | thousands by filing date | |
| SYNEOS HEALTH INC | 87166B102 | CL A | 101,953 | $6,946,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 681,243 | $6,397,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 66,585 | $6,055,000 | thousands by filing date | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 73,104 | $6,045,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 290,465 | $6,013,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 1,078,177 | $5,811,000 | thousands by filing date | |
| ADAPTHEALTH CORP | 00653Q102 | COMMON STOCK | 150,414 | $5,650,000 | thousands by filing date | |
| ELUTIA INC | 05479K106 | CL A COM | 408,213 | $5,564,000 | thousands by filing date | |
| ACCENDRA HEALTH INC | 690732102 | COM | 204,384 | $5,529,000 | thousands by filing date | |
| AVANTOR INC COM | 05352A100 | Stock | 194,777 | $5,483,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 207,293 | $5,390,000 | thousands by filing date | |
| Cigna Corporation | 125523100 | COM | 25,085 | $5,222,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 28,378 | $4,838,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 124,323 | $4,139,000 | thousands by filing date | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 19,834 | $4,037,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 172,047 | $3,735,000 | thousands by filing date | |
| MUSTANG BIO INC | 62818Q104 | COM | 892,027 | $3,376,000 | thousands by filing date | |
| GOODRX HLDGS INC | 38246G108 | COM CL A | 77,379 | $3,121,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 7,504 | $3,079,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 990,563 | $3,001,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 56,891 | $2,844,000 | thousands by filing date | |
| ANGIODYNAMICS INC | 03475V101 | COM | 184,901 | $2,835,000 | thousands by filing date | |
| PRA HEALTH SCIENCES INC | 69354M108 | COM | 21,590 | $2,708,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 54,221 | $2,516,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 133,648 | $2,362,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 38,313 | $2,300,000 | thousands by filing date | |
| IMMUNIC INC | 4525EP101 | COM | 138,613 | $2,119,000 | thousands by filing date | |
| ZOETIS INC CL A | 98978V103 | Stock | 12,691 | $2,100,000 | thousands by filing date | |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 477,895 | $2,093,000 | thousands by filing date | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W114 | UNIT 10/23/2027 | 195,000 | $2,079,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 151,820 | $1,823,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 42,292 | $1,586,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 14,919 | $1,220,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 226,593 | $1,181,000 | thousands by filing date | |
| PENNANT GROUP INC | 70805E109 | COM | 18,227 | $1,058,000 | thousands by filing date | |
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 63,455 | $955,000 | thousands by filing date | |
| SENSEONICS HLDGS INC | 81727UAA3 | NOTE 5.250% 2/0 | 1,500,000 | $638,000 | thousands by filing date | |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 206,561 | $382,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 45,682 | $346,000 | thousands by filing date | |
| F-STAR THERAPEUTICS INC | 30315R107 | COM | 20,445 | $202,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001633055-21-000002 | this filing | 2021-02-16 | acceptance time not in the bulk data set |